Pharmacology has been at it a long time. Precursor to the Western pill-based prescription for all that ails, it stands on the shoulders of a thousands-generations long compilation of the knowledge of ...

We recently published a list of Jim Cramer Reveals Trump’s Potential Secret Weapon In China Trade Talks & Discusses These 10 ...

Investors are worried Novo Nordisk's competition with Eli Lilly is heating up and that the first-to-market GLP-1 leader is ...

In this week’s edition of InnovationRx, we look at Aetna’s withdrawal from the ACA exchanges, the potential for digital ...

The nationwide withdrawal, affecting roughly 1 million people in the United States, comes amid chaos in the government health ...

Pharmaceutical company Novo Nordisk (NVO) came out swinging Wednesday morning as the stock initially jumped on its first quarter earnings beat ($0.99 per share vs. estimates of $0.94). Revenue figures ...

Activist investor Glenview Capital Management has reduced its ownership stake in CVS Health (NYSE:CVS) after the pharmacy ...

Eli Lilly won’t lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an ...

Payer profits fell in 2024 as Americans, especially older ones, utilized more medical care. But efforts to resuscitate ...

Health insurers, employers and pharmacy benefit managers may be insulated from the immediate effects of drug tariffs, but ...

Quintin Cook, 27, appeared before a judge on Friday. He is accused of vulgar indecent exposure and battering a woman at a CVS ...

Consumers, doctors and other advocates agree pharmacy benefit managers (PBMs) wield too much power and influence over patients’ access to medicines and their prices.